# Blood Bank Of Delmarva, a Division of New York Blood Center, Inc. – FDA Inspection, Feb 11, 2020

Source: https://www.keypedia.com/records/fda_inspections/blood-bank-of-delmarva-a-division-of-new-york-blood-center-inc/bd3ff83c-84e7-4bad-b1ac-06bbc9d4e229
Source feed: FDA_Inspections

> FDA inspection 1117609 of Blood Bank Of Delmarva, a Division of New York Blood Center, Inc., February 11, 2020. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 630. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1117609
- Company Name: Blood Bank Of Delmarva, a Division of New York Blood Center, Inc.
- Inspection Date: 2020-02-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1251717 - 2024-09-24
- FDA Inspection 1045164 - 2018-03-09
- FDA Inspection 1046316 - 2018-02-20
- [FDA Inspection 964016 - 2016-02-02](https://www.keypedia.com/records/fda_inspections/blood-bank-of-delmarva-a-division-of-new-york-blood-center-inc/ac2fb71f-9504-4875-801a-98dfee787288)
- FDA Inspection 863672 - 2014-01-28

Company: https://www.keypedia.com/companies/blood-bank-of-delmarva-a-division-of-new-york-blood-center-inc/184c00da-afce-4c46-bc68-09f608b78abe

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
